Esketamine multi-omic biomarker evaluation in major depressive disorder (EMBER-MDD): concept, objectives and methodologies of a non-clinical investigator-initiated study

European Archives of Psychiatry and Clinical Neuroscience · Published 2026-06-30 · DOI 10.1007/s00406-026-02306-x

Free full text

Authors (6)

C. Hohoff, T. Lange, L. Steinbach, S. M. Wissing, E. Van Assche, B. T. Baune

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Hohoff, C., Lange, T., Steinbach, L., et al. (2026). Esketamine multi-omic biomarker evaluation in major depressive disorder (EMBER-MDD): concept, objectives and methodologies of a non-clinical investigator-initiated study. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-026-02306-x

Related articles

• Associations between plasma BDNF, VEGF, and EGF and cognition in drug-naïve schizophrenia with and without sleep disturbances · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Distinct effects of current suicidal symptoms and lifetime suicide attempts on C-reactive protein levels and executive function in young people with major affective disorders · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Stressful life events and lifestyle factors are associated with elevated peripheral TNF-α levels in adults with depression without physical diseases · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Family structure, depressive symptoms, and childhood maltreatment in Chinese adolescents: a mediation analysis · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Machine learning-based integration identifies a 10-gene predictive signature and its classification patterns in schizophrenia · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Major depressive disorder-alcohol use disorder comorbidity: diagnosis, mechanisms and treatment · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Efficacy and EEG-ECG mechanisms of taVNS combined with TEAS for negative symptoms of schizophrenia: a protocol for a 2 × 2 factorial randomized controlled trial · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Differential burden of five major mental disorders in the United States across the COVID-19 pandemic · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• The interplay between mental health, ecological factors, and problematic smartphone use: a network analysis in adolescents with major depressive disorder · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Triglyceride–glucose waist-to-height ratio improves risk stratification for depressive symptoms: evidence from NHANES · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal